Redesca · DIN 02509083 · 40 mg/0.4 mL · injection, 0.4 mL pre-filled syringe (preservative-free)
General benefitMarketed · checked November 20, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Redesca · DIN 02509083
Manufacturer: Shenzhen Techdow Pharmaceutical Co., Ltd.; listing date 2021-04-30
Health Canada: Marketed since 2021-04-09 · brand REDESCA · ATC B01AB05 ENOXAPARIN · form Solution · route Intravenous, Subcutaneous · ingredients ENOXAPARIN SODIUM 40 MG/0.4ML · company Shenzhen techdow pharmaceutical co., ltd. · schedule Prescription
Redesca: Formulary list price $6.62 per unit (the source does not state the unit; exact figure $6.6160). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02509083)
Source record
DIN 02509083: Redesca
Raw flags: sec3=Y
Item: 201200107; group id 254; item number 0464; lccId None; manufacturer id SHE
Source form: Inj Sol-0.4mL Pref Syr (Preservative-Free); strength: 40mg/0.4mL
Recorded listing: General benefit
Source prices (unrounded): $6.6160; ministry $6.6160
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02509083
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99840
Shortage status: not checked (no credentials)